Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00589719 · ClinicalTrials.gov registry record
Asthma in the Delta Region of Arkansas (ADRA): Prevalence and Morbidity
A clinical trial of Asthma, sponsored by Arkansas Children's Hospital Research Institute.
- Completed
- Registry status
- 964
- Enrollment target
- 1
- Study location
NCT00589719: Completed study of Asthma, sponsored by Arkansas Children's Hospital Research Institute.
NCT00589719 is a study of Asthma that has completed, run by Arkansas Children's Hospital Research Institute. The registered enrollment target is 964 participants, below the 1,561-participant average among 374 other Asthma trials with a reported enrollment target (38% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00589719, a study of Asthma, has completed, sponsored by Arkansas Children's Hospital Research Institute.
- COMPLETED
- Registry status
- 964 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to conduct a cross-sectional study to examine asthma prevalence and morbidity in a predominately minority, low-income population in rural Arkansas.
Conditions Studied
Study Locations (1)
Arkansas
- Arkansas Children's Hospital Research Institute - Little Rock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 964 participants |
| Start Date | 2005-08 |
| Est. Completion | 2008-08 |
What the finished NCT00589719 record still lists
NCT00589719 is an observational study that tracks outcomes without assigning an intervention. The registered 964 participants enrollment target is mid-sized for trials with a published cap, below the 1,561-participant average among 374 other Asthma trials with a reported enrollment target (38% lower).
The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 0 interventions.
NCT00589719 reports a single indexed study location in Arkansas.
Frequently Asked Questions
What is clinical trial NCT00589719 about?
NCT00589719 is a clinical study titled "Asthma in the Delta Region of Arkansas (ADRA): Prevalence and Morbidity". The purpose of the study is to conduct a cross-sectional study to examine asthma prevalence and morbidity in a predominately minority, low-income population in rural Arkansas.
What is the current status of trial NCT00589719?
This trial is currently completed. The enrollment target is 964 participants. The study started on 2005-08. Estimated completion is 2008-08.
What conditions does trial NCT00589719 study?
This clinical trial studies the following conditions: Asthma.
Who is sponsoring clinical trial NCT00589719?
This trial is sponsored by Arkansas Children's Hospital Research Institute, which has 97 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00589719 being conducted?
This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00589719's enrollment target sits among peer trials
964 44th of 374 higher than 330 of 374 other Asthma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Asthma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Innate Immunity in Allergic Asthma
RECRUITING
-
Automated Inhaler Monitoring for Asthma Medication Usage
RECRUITING · NA
-
Impact of Metabolic Dysfunction and Mucus Plugging on Asthma Physiology
RECRUITING
-
Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
RECRUITING · Phase 3
-
Escitalopram in Asthma Patients With Frequent Exacerbation
RECRUITING · Phase 2
-
Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04726241 · 960 participants · Phase 1
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- NCT05142384 · 960 participants · NA
ICBT (Internet Based Cognitive Behavioral Therapy) for Maternal Depression: Community Implementation in Head Start
- NCT05178498 · 960 participants
Impact of Dietary Inflammatory Potential on Breast Cancer Risk
- NCT05946629 · 960 participants · NA
SELUTION 4 De Novo Small Vessel IDE Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia